de Kruijff CC, Post E, Merkx MM, Rigter IM, Knoester H. Palliatieve sedatie: farmacotherapeutisch stappenplan bij kinderen. Praktische Pediatrie. 2021(2).
Al-Bar MA, Chamsi-Pasha H. End-of-Life Care. 2015. In: Contemporary Bioethics Islamic Perspective [Internet]. Switzerland: Springer; [254]. Available from: https://link.springer.com/content/pdf/10.1007/978-3-319-18428-9.pdf.
Piette V, Beernaert K, Cohen J, Pauwels NS, Scherrens A-l, van der Werff ten Bosch J, et al. Healthcare interventions improving and reducing quality of life in children at the end of life: a systematic review. Pediatric Research. 2021;89(5):1065-77.
Nederlands Kenniscentrum Farmacotherapie bij Kinderen. Kinderformularium. [Available from: https://kinderformularium.nl.
Hohl CM, Stenekes S, Harlos MS, Shepherd E, McClement S, Chochinov HM. Methotrimeprazine for the management of end-of-life symptoms in infants and children. J Palliat Care. 2013;29(3):178-85.
Cortina G, Klingkowski U, Ojinaga V, Neu N, Giner T. Abstract P-471: Safety of levomepromazine for the treatment of refractory agitation in critically ill children. Pediatric Critical Care Medicine. 2018;19(6S):194.
Tobias JD. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children. J Opioid Manag. 2008;4(4):187-91.
Sottas CE, Anderson BJ. Dexmedetomidine: the new all-in-one drug in paediatric anaesthesia? Curr Opin Anaesthesiol. 2017;30(4):441-51.
Burns J, Jackson K, Sheehy KA, Finkel JC, Quezado ZM. The Use of Dexmedetomidine in Pediatric Palliative Care: A Preliminary Study. J Palliat Med. 2017;20(7):779-83.
Wolfe J, Hinds P. Textbook of Interdisciplinary Pediatric Palliative Care: Saunders; 2011.